Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases
Por um escritor misterioso
Descrição
Cancers, Free Full-Text
Cancers, Free Full-Text
BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer
Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases
Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer
The tumor-immune ecosystem in shaping metastasis
Cancers, Free Full-Text
Yongkun WEI, Doctor of Medicine, University of Texas MD Anderson Cancer Center, Texas, MD Anderson, Department of Molecular and Cellular Oncology
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer
Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with De Novo Stage IV Breast Cancer
Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy - ScienceDirect
Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis - ScienceDirect
BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
